EffRx Pharmaceuticals SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:EffRx Pharmaceuticals SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3297
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EffRx Pharmaceuticals SA (EffRx), formerly EffRx Inc is a pharmaceutical company that develops and commercializes prescription medications for specialty indications. The company offers therapeutics for men and women with musculoskeletal, genitourinary and endocrine disorders. It provides commercialized product Binosto, an effervescent tablet for oral solution and treatment of osteoporosis in postmenopausal women. EffRx’s lead development product, EX404 targets polycystic ovarian syndrome in adolescents. The company also offers life cycle management services to pharmaceutical and biotechnology companies. It distributes products through distributors in the US, Australia, South Korea and others. EffRx is headquartered in Schwyz, Switzerland.

EffRx Pharmaceuticals SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EffRx Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 9
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
EffRx Pharma Raises USD2.3 Million in Venture financing 12
Private Equity 13
Sobera Capital Acquires Equity Holdings in 12 Pharma Companies 13
Partnerships 15
EffRx Pharma Enters into Agreement with Andrus 15
EffRx Pharma Enters into Distribution Agreement with Andrus for Binosto 16
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 17
EffRx Pharma Enters An Agreement With Kadmon 18
Abiogen Pharma Enters Into Distribution Agreement With EffRx For Binosto 19
Lacer Enters Into Distribution Agreement With EffRx For Binosto 20
Ascendancy Enters Into Distribution Agreement With EffRx Pharma For Binosto 21
EffRx Pharma Enters Into Distribution Agreement With Ahn-Gook Pharma For Binosto 22
Licensing Agreements 23
Hikma Pharma Enters Into Licensing Agreement With EffRx Pharma For Binosto 23
EffRx Pharma Enters Into Licensing Agreement With Mission Pharmacal For Binosto 24
EffRx Pharmaceuticals SA – Key Competitors 25
EffRx Pharmaceuticals SA – Key Employees 26
EffRx Pharmaceuticals SA – Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
Corporate Communications 28
Jun 01, 2017: Paolo Agnoluzzi Appointed CFO of EffRx Pharmaceuticals 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Key Facts 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EffRx Pharmaceuticals SA, Deals By Therapy Area, 2012 to YTD 2018 8
EffRx Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 9
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EffRx Pharma Raises USD2.3 Million in Venture financing 12
Sobera Capital Acquires Equity Holdings in 12 Pharma Companies 13
EffRx Pharma Enters into Agreement with Andrus 15
EffRx Pharma Enters into Distribution Agreement with Andrus for Binosto 16
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 17
EffRx Pharma Enters An Agreement With Kadmon 18
Abiogen Pharma Enters Into Distribution Agreement With EffRx For Binosto 19
Lacer Enters Into Distribution Agreement With EffRx For Binosto 20
Ascendancy Enters Into Distribution Agreement With EffRx Pharma For Binosto 21
EffRx Pharma Enters Into Distribution Agreement With Ahn-Gook Pharma For Binosto 22
Hikma Pharma Enters Into Licensing Agreement With EffRx Pharma For Binosto 23
EffRx Pharma Enters Into Licensing Agreement With Mission Pharmacal For Binosto 24
EffRx Pharmaceuticals SA, Key Competitors 25
EffRx Pharmaceuticals SA, Key Employees 26

List of Figures
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EffRx Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EffRx Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[EffRx Pharmaceuticals SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Perenco Holdings-石油・ガス分野:企業M&A・提携分析
    Summary Perenco Holdings (Perenco) is an independent upstream energy company. It explores for, develops, produces, transports, and stores oil and gas. The company’s oil fields ranges from Northern Europe to Africa and Latin America to Southeast Asia. Through spot sales and long term sales agreements …
  • MEC Resources Ltd (MMR):企業の財務・戦略的SWOT分析
    MEC Resources Ltd (MMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Constantia Industries AG:企業の戦略的SWOT分析
    Constantia Industries AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Rizzani De Eccher S.P.A.
    Rizzani De Eccher S.P.A. - Strategy, SWOT and Corporate Finance Report Summary Rizzani De Eccher S.P.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Outokumpu Oyj:戦略・SWOT・企業財務分析
    Outokumpu Oyj - Strategy, SWOT and Corporate Finance Report Summary Outokumpu Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Alibaba Pictures Group Limited:企業のM&A・事業提携・投資動向
    Alibaba Pictures Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alibaba Pictures Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Alimentation Couche-Tard Inc. (ATD.B):企業の財務・戦略的SWOT分析
    Alimentation Couche-Tard Inc. (ATD.B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Credit Du Nord Sa
    Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report Summary Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Viking Therapeutics Inc (VKTX):企業の財務・戦略的SWOT分析
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. Its lead clinical program product candidate include VK5211, an orally available, non-steroidal selective an …
  • Lonestar Resources US Inc (LONE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lonestar Resources US Inc (Lonestar) is an independent oil and gas company that focuses on acquisition, exploration, development and production of oil and natural gas resources. Lonestar holds majority of the working interests in its properties and manages activities related to designing and …
  • Walmart de Mexico y Centroamerica:企業の戦略・SWOT・財務情報
    Walmart de Mexico y Centroamerica - Strategy, SWOT and Corporate Finance Report Summary Walmart de Mexico y Centroamerica - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • American Axle & Manufacturing Holdings, Inc.
    American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • NextEra Energy Inc (NEE)-エネルギー分野:企業M&A・提携分析
    Summary NextEra Energy, Inc. (NEE), formerly FPL Group, Inc., is an energy company that generates, transmits and distributes electricity together with its subsidiaries. The company generates power through various sources such as nuclear, coal, oil and natural gas-fired facilities, and hydro power pl …
  • Day & Zimmermann Group, Inc.:企業の戦略・SWOT・財務分析
    Day & Zimmermann Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Day & Zimmermann Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Public Joint-Stock Company Commercial Bank PrivatBank:企業の戦略・SWOT・財務情報
    Public Joint-Stock Company Commercial Bank PrivatBank - Strategy, SWOT and Corporate Finance Report Summary Public Joint-Stock Company Commercial Bank PrivatBank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • American Greetings Corporation (AM):企業の戦略的SWOT分析
    American Greetings Corporation (AM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • El Al Israel Airlines Ltd.:企業の戦略・SWOT・財務情報
    El Al Israel Airlines Ltd. - Strategy, SWOT and Corporate Finance Report Summary El Al Israel Airlines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Shinsei Bank Ltd:企業のM&A・事業提携・投資動向
    Shinsei Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shinsei Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • INRange Systems Inc-医療機器分野:企業M&A・提携分析
    Summary INRange Systems Inc (INRange) is a medical device company that develops and markets remote management systems for the healthcare sector. The company provides remote medication management system to improve adherence to medication therapy by remotely managing, storing, delivering, and monitori …
  • Biocon Ltd (BIOCON):企業の財務・戦略的SWOT分析
    Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆